Year |
Citation |
Score |
2018 |
Wong TN, Miller CA, Jotte MRM, Bagegni N, Baty JD, Schmidt AP, Cashen AF, Duncavage EJ, Helton NM, Fiala M, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, et al. Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Nature Communications. 9: 455. PMID 29386642 DOI: 10.1038/S41467-018-02858-0 |
0.598 |
|
2017 |
Wong TN, Miller CA, Jotte MR, Bagegni N, Baty JD, Schmidt AE, Cashen AF, Duncavage EJ, Helton NM, Fiala MA, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, et al. Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential Blood. 130: 469-469. DOI: 10.1182/Blood.V130.Suppl_1.469.469 |
0.513 |
|
2016 |
Welch JS, Petti AA, Miller CA, Fronick CC, O'Laughlin M, Fulton RS, Wilson RK, Baty JD, Duncavage EJ, Tandon B, Lee YS, Wartman LD, Uy GL, Ghobadi A, Tomasson MH, ... ... Janke MR, et al. TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. The New England Journal of Medicine. 375: 2023-2036. PMID 27959731 DOI: 10.1056/Nejmoa1605949 |
0.58 |
|
2016 |
Duncavage EJ, O'Brien J, Vij K, Miller CA, Chang GS, Shao J, Jacoby MA, Heath S, Janke MR, Elliott K, Fulton RS, Fronick C, O'Laughlin M, Westervelt P, Ley TJ, et al. Targeted sequencing informs the evaluation of normal karyotype cytopenic patients for low-grade myelodysplastic syndrome. Leukemia. PMID 27573557 DOI: 10.1038/Leu.2016.247 |
0.473 |
|
2015 |
Duncavage EJ, O'Brien J, Vij KR, Miller CA, Shao J, Jacoby MA, Fulton RS, Heath S, Janke M, Fronick CC, O'Laughlin M, Wilson RK, Ley TJ, Walter MJ. Detection of Clonal Hematopoiesis in Cytopenic Patients Using Targeted Sequencing Blood. 126: 1654-1654. DOI: 10.1182/Blood.V126.23.1654.1654 |
0.561 |
|
2013 |
Janke MR, Baty JD, Graubert TA. SWR/J mice are susceptible to alkylator-induced myeloid leukemia. Blood Cancer Journal. 3: e161. PMID 24241401 DOI: 10.1038/Bcj.2013.59 |
0.571 |
|
2008 |
Janke MR, Babatunde F, Cahan P, Cheverud JM, Graubert TA. MLF1 Is a Candidate Susceptibility Factor for T-AML That Induces Apoptosis in Normal Hematopoietic Cells Blood. 112: 310-310. DOI: 10.1182/Blood.V112.11.310.310 |
0.574 |
|
Show low-probability matches. |